0001225208-24-005567.txt : 20240503
0001225208-24-005567.hdr.sgml : 20240503
20240503163119
ACCESSION NUMBER: 0001225208-24-005567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240501
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REED JOHN C
CENTRAL INDEX KEY: 0001181561
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24913719
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLAZA
STREET 2: WHQ 2134
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-05-01
0000200406
JOHNSON & JOHNSON
JNJ
0001181561
REED JOHN C
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, Innovative Medicine, R&D
0
Common Stock
2024-05-01
4
M
0
22255.0000
0.0000
A
22561.0000
D
Common Stock
2024-05-01
4
F
0
10984.0000
144.5900
D
11577.0000
D
Restricted Share Units
2024-05-01
4
M
0
22255.0000
0.0000
D
Common Stock
22255.0000
53510.0000
D
The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
Shares withheld for payment of taxes upon vesting of Restricted Share Units.
/s/ Raavi Deol, as attorney-in-fact for John C. Reed
2024-05-03